neurodiem-image

Oligonucleotide therapies and the promise of precision medicine in epilepsy

In a workshop held at AES 2019, the development of novel oligonucleotide therapies (OGNs) was discussed. A series of leading specialists offered their views on how OGNs could influence epilepsy management and lead to more personalized or precision medicine.